Rio de Janiero, Brazil. October 2014 Lecture Topic: Social Media in Medicine Category: Social media
Rio de Janiero, Brazil. October 2014 Lecture Topic: Social Media in Medicine Category: Social media
Rome, Italy. February 2015 Lecture topic: PSA Screening Yes or No Category: Prostate Cancer
Florence, Italy. October 2014 Lecture Topic: Social Media in Urology Category: Social Media
Rome, Italy. April 2013 Lectures Topic: Nature vs Nurture in Prostate Cancer, and Prostate Specific Antigen Velocity Category: Prostate Cancer
Banks JA, McGuire BB, Loeb S, Shrestha S, Helfand BT, Catalona WJ. “Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy.” Urologic Oncology 2012, epub Jan 25. PMID: 22285005. Link: http://www.ncbi.nlm.nih.gov/pubmed/22285005
Loeb S, Schaeffer EM, Chan DW, Carter HB, Walsh PC, and Sokoll LJ. “Investigation of Human Anti-Mouse Antibodies As Potential Cause of Postprostatectomy PSA Elevation.” Urology, May 2009; 73: 947. Link: http://www.ncbi.nlm.nih.gov/pubmed/19394489
Loeb S, Roehl KA, Viprikasit DP, and Catalona WJ. “Long-Term Rates of Undetectable PSA with Initial Observation and Delayed Salvage Radiotherapy after Radical Prostatectomy.” European Urology, July 2008; 54: 88. Link: http://www.ncbi.nlm.nih.gov/pubmed/18400368
Madrid, Spain. March 2015 Lecture Topics: Prognostic Factors in the Prostate Histology, Social Media Categories: Prostate Cancer, Social Media, Erectile Dysfunction
Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, and Walsh PC. “Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?” Journal of Urology August 2011; 186: 500. PMID: 21679999. Link: http://www.ncbi.nlm.nih.gov/pubmed/21679999 Patients often ask whether it is necessary to continue PSA testing indefinitely after radical prostatectomy. In the Johns Hopkins… Read More
Loeb S, Makarov DV, Schaeffer EM, Humphreys EB, and Walsh PC. “Prostate-specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.” Journal of Urology, July 2010; 184: 157. Link: http://www.ncbi.nlm.nih.gov/pubmed/20483148 In men with newly diagnosed prostate cancer, bone metastases are uncommon at PSA levels <20 ng/ml. However, after radical prostatectomy… Read More
Madrid, Spain. February 2014 Lecture topic: Smarter Prostate Cancer Screening Category: Prostate Cancer
Rotterdam, Netherlands. November 2010 Lecture Topic: Prostate Cancer Category: Prostate Cancer
Budapest, Hungary. March 2011 Lecture Topics: Debate on Active Surveillance, Panel on Controversies in Prostate Cancer Category: Prostate Cancer
Stockholm, Sweden. April 2014 Lecture Topic: Invited lecture on Standardizing Report and Outcome of Surgery in Prostate Cancer Category: Prostate Cancer
Hemavan, Sweden. January 2012 Lecture topic: Prostate Cancer Risk among immigrants to Sweden Category: Prostate Cancer
Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. “Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification.” European Urology 2014 Oct epub. PMID: 25457014. Link: http://www.ncbi.nlm.nih.gov/pubmed/25457014 This systematic review examined the utility of markers, genetic factors and risk stratification for… Read More
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. “Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer.” Journal of Urology October 2012; 188: 1131-6. PMID: 22901577. Link: http://www.ncbi.nlm.nih.gov/pubmed/22901577 Longitudinal measurements of the Prostate Health Index (phi)… Read More
Loeb S. Editorial comment on “Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.” Urology 2015; 85: 21-2. PMID 25530360 Link: http://www.ncbi.nlm.nih.gov/pubmed/25530360
Loeb S. “Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for ‘Prime Time’?” European Urology 2014 Nov epub. PMID: 25465339. Link: http://www.ncbi.nlm.nih.gov/pubmed/25465339
Loeb S. “Editorial comment on ‘Current Ability of Multiparametric Prostate MRI and Targeted Biopsy to Improve the Detection of Prostate Cancer’” Urology Practice 2014 May; 1: 20.
Loeb S. Editorial Comment on “Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.” Urology 2014; 84: 1006-7. PMID: 25443895. Link: http://www.ncbi.nlm.nih.gov/pubmed/25443895
Loeb S, Metter EJ, and Carter HB. “Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection.” Journal of the National Cancer Institute November 2011; 103: 1636. PMID: 21926375. Link: http://www.ncbi.nlm.nih.gov/pubmed/21926375
Davuluri M, Loeb S. “Prevalence of Infections Associated with Prostate Biopsy.” Reviews in Urology 2014; 16: 156. PMID: 25337051. Link: http://www.ncbi.nlm.nih.gov/pubmed/25337051
Loeb S, Kettermann A, Carter HB, Metter EJ, Ferrucci L, and Walsh PC. “Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging.” Journal of Urology 2009 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19683305
Martin NE, Chen MH, Catalona WJ, Loeb S, Roehl KA, and D’Amico AV. “The Influence of Serial Prostate-Specific Antigen Screening on the PSA Velocity at Diagnosis.” Cancer, 2008; 113: 717. Link: http://www.ncbi.nlm.nih.gov/pubmed/18615505
Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, and Carter HB. “PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging.” European Urology, July 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/18614274
Loeb S and Carter HB. “Limitations and Use of PSA Derivatives in the Screening and Risk Stratification of Prostate Cancer.” Urologic Oncology: Seminars and Original Investigations, Nov-Dec 2009; 27: 583. Link: http://www.ncbi.nlm.nih.gov/pubmed/19879470
Loeb S. “Guideline of guidelines: prostate cancer screening.” BJU International 2014 September; 114: 323. PMID: 24981126. Link: http://www.ncbi.nlm.nih.gov/pubmed/23567643
Loeb S, Sutherland DE, D’Amico AV, Roehl KA, and Catalona WJ. “PSA Velocity is Associated with Gleason Score in Radical Prostatectomy Specimen: Marker for Prostate Cancer Aggressiveness.” Urology, June 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/18571700
Eggener SE, Yossepowitch O, Roehl KA, Loeb S, Yu X, and Catalona WJ. “The Relationship of PSA Velocity to Histologic Findings in a Prostate Cancer Screening Program.” Urology 2008; 71: 1016. Link: http://www.ncbi.nlm.nih.gov/pubmed/18358515
Loeb S, Roehl KA, Catalona WJ, and Nadler RB. “Is the Utility of PSA Velocity for Prostate Cancer Detection Affected by Age?” BJU International, April 2008; 101: 817. Link: http://www.ncbi.nlm.nih.gov/pubmed/18321315
Loeb S. Editorial Comment on: “Outcomes of Fecal Carriage of Extended-Spectrum β-Lactamase After Transrectal Ultrasound-Guided Biopsy of the Prostate.” Urology 2014 epub. PMID 25239260. Link: http://www.ncbi.nlm.nih.gov/pubmed/25239260
Bratt O, Folkvaljon Y, Loeb S, Klotz L, Egevad L, Stattin P. “Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.” BJU International 2014, July epub. PMID: 25053197. Link: http://www.ncbi.nlm.nih.gov/pubmed/25053197
Loeb S. “Prediction of Outcomes After Radical Prostatectomy in Patients Diagnosed with Prostate Cancer of Biopsy Gleason Score ≥8 Via Contemporary Multi (≥12)-Core Prostate Biopsy.” BJU International 2011; 108: 222. PMID: 21718432. Link: http://www.ncbi.nlm.nih.gov/pubmed/21718432
Loeb S and Schaeffer EM. “Risk Factors, Prevention, and Early Detection of Prostate Cancer.” Primary Care Clinics of North America, September 2009; 36: 603. Link: http://www.ncbi.nlm.nih.gov/pubmed/19616157
Bostrӧm PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, and Cooperberg MR. “Genomic Predictors of Outcome in Prostate Cancer.” European Urology 2015 epub. PMID: 25913390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25913390
Barranquilla, Colombia. October 2015 Lecture Topics (all in Spanish): Prostate -specific Antigen and Biomarkers, Prevention and Management of Prostate Biopsy Complications, Active Surveillance Category: Prostate Cancer
Ohmann EL, Loeb S, Robinson D, Bill-Axelson A, Berglund A, and Stattin P. “Nationwide Population-Based Study of Prostate Cancer Stage Migration Between and Within Clinical Risk Categories.” Scandinavian Journal of Urology 2014 March epub. PMID: 24581522 Link: http://www.ncbi.nlm.nih.gov/pubmed/24611795
Loeb S and Partin AW. “Randomized Trials of Prostate Cancer Screening.” Reviews in Urology, Summer 2009; 11: 179. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777067/
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA. “Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?” Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390